Last reviewed · How we verify

NCT06607523

The Gut-Brain Axis During Neurorehabilitation; Prebiotic Treatment to Alter the Gut Microbiome and Neurologic Symptoms

Recruiting now NA Last updated 19 December 2025
What this trial tests

NA trial testing Inulin in Brain Injuries in 130 participants. Currently enrolling.

Timeline
6 March 2025
Primary endpoint
1 October 2028
1 October 2028

Quick facts

Lead sponsorThe University of Texas Medical Branch, Galveston
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment130
Start date6 March 2025
Primary completion1 October 2028
Estimated completion1 October 2028
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

The University of Texas Medical Branch, Galveston

Who can join

18 and older, any sex, with Brain Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to characterize the microbiome of patients undergoing post-acute residential neurorehabilitation compared to community controls and to determine if a dietary fiber, Inulin, can create a shift in the microbiome leading to changes in fatigue and cognition.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Inulin

Trials testing the same drug.

Other recruiting trials for Brain Injuries

Currently open trials in the same condition.

Other The University of Texas Medical Branch, Galveston trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06607523.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing